MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 17, 2007; DOI: 10.1124/mol.107.040451


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.040451v1
73/1/82    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boverhof, D. R
Right arrow Articles by Zacharewski, T. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boverhof, D. R
Right arrow Articles by Zacharewski, T. R


Received for publication August 2, 2007.
Revised October 17, 2007.
Accepted for publication October 17, 2007.

Inhibition of estrogen-mediated uterine gene expression responses by dioxin

Darrell R Boverhof 1, Lyle D Burgoon 1, Kurt J Williams 1, Timothy R Zacharewski 1*

1 Michigan State University

* Address correspondence to: E-mail: tzachare{at}msu.edu

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) exhibits antiestrogenic properties including the inhibition of estrogen-induced uterine growth and proliferation. The inhibition of estrogen-mediated gene expression through ER/AhR crosstalk has been proposed as a plausible mechanism, however, only a limited number of inhibited responses have been investigated which are unlikely to fully account for the anti-uterotrophic effects of TCDD. Therefore, the effects of TCDD on ethynyl estradiol (EE) mediated uterine gene expression were investigated using cDNA microarrays with complementary physiological and histological phenotypic anchoring. Mice were gavaged with either vehicle, 3 daily doses of 10 µg/kg EE, a single dose of 30 µg/kg TCDD or a combination of EE plus TCDD and sacrificed after 4, 12, 24 and 72 hours. TCDD cotreatment inhibited EE induced uterine wet weight by 37, 23 and 45% at 12, 24 and 72 hrs, respectively. TCDD cotreatment also reduced EE-mediated stromal edema, hypertrophy and hyperplasia and induced marked luminal epithelial cell apoptosis. A 2 x 2 factorial microarray design was used to identify EE- and TCDD-specific differential gene expression responses as well as their interactive effects. Only 133 of the 2,753 EE-mediated differentially expressed genes were significantly modulated by TCDD cotreatment, indicating a gene-specific inhibitory response. The EE-mediated induction of many genes, including trefoil factor 1 and keratin 14, were inhibited by greater than 90% by TCDD. Functional annotation of inhibited responses was associated with cell proliferation, water and ion transport, and maintenance of cellular structure and integrity. These inhibited responses correlate with the observed histological alterations and may contribute to the anti-uterotrophic effects of TCDD.


Key words: Sex hormones, Regulation of gene expression, Ah receptor, Toxicant-induced gene express


This article has been cited by other articles:


Home page
Toxicol SciHome page
G. P. Daston
Gene Expression, Dose-Response, and Phenotypic Anchoring: Applications for Toxicogenomics in Risk Assessment
Toxicol. Sci., October 1, 2008; 105(2): 233 - 234.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics